{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:44:10Z","timestamp":1793270650053,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["LNKX2025CY02"],"award-info":[{"award-number":["LNKX2025CY02"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU-24035"],"award-info":[{"award-number":["CMU-24035"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["LJKMZ20221199"],"award-info":[{"award-number":["LJKMZ20221199"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010086","name":"Foundation of Liaoning Province Education Administration","doi-asserted-by":"publisher","award":["2025MS220"],"award-info":[{"award-number":["2025MS220"]}],"id":[{"id":"10.13039\/501100010086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biomaterials.2025.123548","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:16:22Z","timestamp":1752578182000},"page":"123548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Recent advances in exosome-based nanodelivery systems for Parkinson's disease"],"prefix":"10.1016","volume":"325","author":[{"given":"Yongqiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3180-2685","authenticated-orcid":false,"given":"Jun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.biomaterials.2025.123548_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"9996","key":"10.1016\/j.biomaterials.2025.123548_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson's disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson's disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2025.123548_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","article-title":"Does Parkinson's disease start in the gut?","volume":"135","author":"Lionnet","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biomaterials.2025.123548_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.biomaterials.2025.123548_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40520-017-0836-2","article-title":"Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson's disease: a systematic review with meta-analysis","volume":"30","author":"dos Santos Delabary","year":"2018","journal-title":"Aging Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson's disease genetics and pathophysiology","volume":"44","author":"V\u00e1zquez-V\u00e9lez","year":"2021","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112343","article-title":"Composition of intestinal flora affects the risk relationship between Alzheimer's disease\/Parkinson's disease and cancer","volume":"145","author":"Hang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123548_bib13","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1016\/j.scib.2024.10.027","article-title":"Targeting modulation of intestinal flora through oral route by an antimicrobial nucleic acid-loaded exosome-like nanovesicles to improve Parkinson's disease","volume":"69","author":"Cui","year":"2024","journal-title":"Science Bulletin"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3748\/wjg.v30.i3.225","article-title":"Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy","volume":"30","author":"Yuan","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117182","article-title":"Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics","volume":"319","author":"Lu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123548_bib16","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib17","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"issue":"41","key":"10.1016\/j.biomaterials.2025.123548_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201804144","article-title":"Dopaminergic neurons transplanted using cell\u2010instructive biomaterials alleviate Parkinsonism in rodents","volume":"28","author":"Adil","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123548_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2020.11.021","article-title":"Neurodegenerative diseases and effective drug delivery: a review of challenges and novel therapeutics","volume":"330","author":"Akhtar","year":"2021","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00415-020-10291-x","article-title":"Nanoparticles for drug delivery in Parkinson's disease","volume":"268","author":"Baskin","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2020.11.049","article-title":"Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: a review","volume":"329","author":"Bellotti","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201800927","article-title":"3D cultures of Parkinson's disease\u2010specific dopaminergic neurons for high content phenotyping and drug testing","volume":"6","author":"Bolognin","year":"2019","journal-title":"Adv. Sci."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123548_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105854","article-title":"Biomimetic lipopolysaccharide\u2010free bacterial outer membrane\u2010functionalized nanoparticles for brain\u2010targeted drug delivery","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib24","article-title":"Curcumin-loaded ceria nanoenzymes for dual-action suppression of inflammation and alleviation of oxidative damage in the treatment of acute lung injury","author":"Huang","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2025.123548_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","article-title":"Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies","volume":"358","author":"Liao","year":"2023","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib26","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1021\/acs.molpharmaceut.2c00383","article-title":"Recent advances in targeted nanotherapies for ischemic stroke","volume":"19","author":"Liao","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123548_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212876","article-title":"A novel nanoparticle system targeting damaged mitochondria for the treatment of Parkinson's disease","volume":"138","author":"Chen","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.biomaterials.2025.123548_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","article-title":"Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: towards a new approach for the management of Parkinson's disease","volume":"321","author":"de Oliveira Junior","year":"2020","journal-title":"J. Contr. Release"},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123548_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105586","article-title":"Exosomes\u2010loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth","volume":"9","author":"Fan","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","article-title":"Parkinson's disease from the gut","volume":"1693","author":"Liddle","year":"2018","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cns.13549","article-title":"Quality of life in Parkinson's disease: a systematic review and meta\u2010analysis of comparative studies","volume":"27","author":"Zhao","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biomaterials.2025.123548_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.compbiomed.2018.09.008","article-title":"Parkinson's disease: cause factors, measurable indicators, and early diagnosis","volume":"102","author":"Bhat","year":"2018","journal-title":"Comput. Biol. Med."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123548_bib33","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2174\/0929867325666171129124616","article-title":"Metals and Parkinson's disease: mechanisms and biochemical processes","volume":"25","author":"Bjorklund","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib35","series-title":"Animal Models of Parkinson's Disease","first-page":"83","author":"Konnova","year":"2018"},{"key":"10.1016\/j.biomaterials.2025.123548_bib36","series-title":"Parkinson's Disease: Etiology, Neuropathology, and Pathogenesis","first-page":"3","author":"Kouli","year":"2018"},{"key":"10.1016\/j.biomaterials.2025.123548_bib37","series-title":"Pharmacological Treatment of Parkinson's Disease","first-page":"129","author":"Zahoor","year":"2018"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123548_bib38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1109\/JBHI.2018.2866873","article-title":"Multimodal assessment of Parkinson's disease: a deep learning approach","volume":"23","author":"V\u00e1squez-Correa","year":"2018","journal-title":"IEEE journal of biomedical and health informatics"},{"key":"10.1016\/j.biomaterials.2025.123548_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"I","key":"10.1016\/j.biomaterials.2025.123548_bib40","first-page":"4138","article-title":"Hereditary-genealogical features of Parkinson'S disease and their early detection of the disease","author":"Abdukodirov","year":"2022","journal-title":"Int. J. Health Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123548_bib41","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson's disease","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib42","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson's disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123548_bib43","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson's disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.biomaterials.2025.123548_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123548_bib47","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson's disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"s2","key":"10.1016\/j.biomaterials.2025.123548_bib48","first-page":"S281","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: what's the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib50","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/ijms21031170","article-title":"BDNF as a promising therapeutic agent in Parkinson's disease","volume":"21","author":"Palasz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/ijms20030719","article-title":"Novel approaches for the treatment of Alzheimer's and Parkinson's disease","volume":"20","author":"Van Bulck","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jnc.14820","article-title":"Role of the endolysosomal system in Parkinson's disease","volume":"150","author":"Vidyadhara","year":"2019","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123548_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"s1","key":"10.1016\/j.biomaterials.2025.123548_bib54","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.3233\/JPD-181493","article-title":"The search for environmental causes of Parkinson's disease: moving forward","volume":"8","author":"Chen","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JPD-202038","article-title":"The impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities","volume":"10","author":"Helmich","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","article-title":"Initiation of pharmacological therapy in Parkinson's disease: when, why, and how","volume":"19","author":"de Bie","year":"2020","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","article-title":"Parkinson's disease in the Western Pacific Region","volume":"18","author":"Lim","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117345","article-title":"The benefits and mechanisms of exercise training for Parkinson's disease","volume":"245","author":"Feng","year":"2020","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123548_bib63","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","article-title":"The burden of Parkinson's disease: a worldwide perspective","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib64","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","article-title":"Network imaging biomarkers: insights and clinical applications in Parkinson's disease","volume":"17","author":"Schindlbeck","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib67","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/STROKEAHA.117.018292","article-title":"Exosome therapy for stroke","volume":"49","author":"Chen","year":"2018","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","article-title":"Gait impairments in Parkinson's disease","volume":"18","author":"Mirelman","year":"2019","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib69","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib70","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00000539-200205000-00034","article-title":"Dystonic reaction to propofol attenuated by benztropine (Cogentin)","volume":"94","author":"Schramm","year":"2002","journal-title":"Anesth. Analg."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/01616412.2017.1297911","article-title":"Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease","volume":"39","author":"Liu","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.biomaterials.2025.123548_bib72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11055-007-0050-3","article-title":"Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson's disease","volume":"37","author":"Fedorova","year":"2007","journal-title":"Neurosci. Behav. Physiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/03639045.2015.1020219","article-title":"Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs","volume":"42","author":"Li","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib74","first-page":"1052","article-title":"Tolcapone (Tasmar\u2122)","volume":"160","author":"Robertson","year":"1999","journal-title":"CMAJ (Can. Med. Assoc. J.): Can. Med. Assoc. J."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ijnp\/pyac021","article-title":"Clinical pharmacology of entacapone (Comtan) from the FDA reviewer","volume":"25","author":"Habet","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1_suppl_1","key":"10.1016\/j.biomaterials.2025.123548_bib76","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1212\/WNL.62.1_suppl_1.S64","article-title":"Levodopa\/carbidopa\/entacapone (Stalevo)","volume":"62","author":"Hauser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biomaterials.2025.123548_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01253772","article-title":"Failure of l-adamantanamine (Symmetrel\u00ae) to modify influenza virus-induced pyrogenicity","volume":"31","author":"Grossgebauer","year":"1970","journal-title":"Arch. Gesamte Virusforsch."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123548_bib78","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.1949.02900520003002","article-title":"Artane\u00ae therapy for parkinsonism: a preliminary study of results in one hundred and seventeen cases","volume":"140","author":"Doshay","year":"1949","journal-title":"J. Am. Med. Assoc."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123548_bib79","first-page":"1","volume":"20","author":"Woelfel","year":"2004","journal-title":"Parcopa (carbidopa-levodopa orally disintegrating tablets), Pharmacist\u2019s Letter & Prescriber\u2019s Letter"},{"issue":"17_supplement_2","key":"10.1016\/j.biomaterials.2025.123548_bib80","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1212\/WNL.0000000000202558","article-title":"Use of real-world data to evaluate the importance of antiemetic pretreatment for apomorphine hydrochloride [APO, Apokyn\u00ae] subcutaneous injection initiation and maintenance in people with Parkinson disease (P13-11.016)","volume":"100","author":"Happel","year":"2023","journal-title":"Neurology"},{"issue":"7 Supplement 2","key":"10.1016\/j.biomaterials.2025.123548_bib81","first-page":"S2","article-title":"Zelepar: fast-dissolving selegiline tablets\u00bb Larry Hoover","volume":"63","author":"Tetrud","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib82","first-page":"24","article-title":"Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect\u00ae), Neurology, Neuropsychiatry","volume":"3","author":"Nodel","year":"2011","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123548_bib83","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/17425255.2016.1194393","article-title":"Clinical pharmacology and efficacy of rotigotine (Neupro\u00ae patch) in the treatment of restless leg syndrome","volume":"12","author":"Ferini-Strambi","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib84","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-94-3-364","article-title":"Sinemet and the treatment of parkinsonism","volume":"94","author":"Boshes","year":"1981","journal-title":"Ann. Intern. Med."},{"issue":"14_supplement_1","key":"10.1016\/j.biomaterials.2025.123548_bib85","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.0000000000002510","article-title":"Advances in levodopa therapy for Parkinson disease: review of RYTARY (carbidopa and levodopa) clinical efficacy and safety","volume":"86","author":"Dhall","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00207454.2016.1193862","article-title":"Outpatient titration of carbidopa\/levodopa enteral suspension (Duopa)","volume":"127","author":"Pahwa","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123548_bib87","first-page":"622","article-title":"Xadago (Safinamide): a Monoamine oxidase B inhibitor for the adjunct treatment of motor symptoms in Parkinson's disease","volume":"42","author":"Cruz","year":"2017","journal-title":"Pharmacy and Therapeutics"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib88","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3233\/JPD-191841","article-title":"Ease LID 2: a 2-year open-label trial of gocovri (amantadine) extended release for dyskinesia in Parkinson's disease","volume":"10","author":"Tanner","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123548_bib89","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1080\/17425247.2021.1960820","article-title":"A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson's disease","volume":"18","author":"Lipp","year":"2021","journal-title":"Expet Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123548_bib90","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jcph.1637","article-title":"Application of clinical pharmacology principles in drug development of modified\u2010release products: leveraging exposure\u2010response information to support approval","volume":"60","author":"AbuAsal","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.12968\/bjcn.2022.27.7.328","article-title":"Sublingual apomorphine therapy as an alternative to complex continuous infusion pumps in advanced Parkinson's disease treatment: a district nurse-led intervention","volume":"27","author":"Macaulay","year":"2022","journal-title":"Br. J. Community Nurs."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib92","first-page":"337","article-title":"Parkinson's Disease","volume":"103","author":"Reich","year":"2018","journal-title":"Med. Clin."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib93","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/mds.27340","article-title":"Medical and surgical management of advanced Parkinson's disease","volume":"33","author":"Antonini","year":"2018","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123548_bib94","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence\u2010based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib95","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease modification in Parkinson's disease: current approaches, challenges, and future considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mdc3.12568","article-title":"Epidemiology of parkinson's disease\u2014East versus West","volume":"5","author":"Abbas","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib97","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.28088","article-title":"Parkinson's disease and COVID\u201019: perceptions and implications in patients and caregivers","volume":"35","author":"Prasad","year":"2020","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib98","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.27414","article-title":"Targeted therapies for Parkinson's disease: from genetics to the clinic","volume":"33","author":"Sardi","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib99","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease\u2014an evidence\u2010based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib102","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41565-018-0179-y","article-title":"Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson's disease","volume":"13","author":"Kim","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib105","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1007\/s00521-018-3689-5","article-title":"A deep learning approach for Parkinson's disease diagnosis from EEG signals","volume":"32","author":"Oh","year":"2020","journal-title":"Neural Comput. Appl."},{"key":"10.1016\/j.biomaterials.2025.123548_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson's disease: implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biomaterials.2025.123548_bib107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","article-title":"Microglia in Parkinson's disease","author":"Ho","year":"2019","journal-title":"Neuroglia in neurodegenerative diseases"},{"key":"10.1016\/j.biomaterials.2025.123548_bib108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","article-title":"The role of dopamine in the brain-lessons learned from Parkinson's disease","volume":"190","author":"Meder","year":"2019","journal-title":"Neuroimage"},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123548_bib109","doi-asserted-by":"crossref","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","article-title":"Diabetes mellitus and Parkinson disease","volume":"90","author":"Pagano","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.biomaterials.2025.123548_bib110","first-page":"213","article-title":"Gender differences in parkinson's disease, neurology and psychiatry of women: a guide to gender-based issues in evaluation","author":"Hayes","year":"2019","journal-title":"Diagnosis, and Treatment"},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2025.123548_bib111","first-page":"S26","article-title":"Parkinson's disease: a review","volume":"66","author":"Radhakrishnan","year":"2018","journal-title":"Neurol. India"},{"key":"10.1016\/j.biomaterials.2025.123548_bib112","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","article-title":"Challenges in the development and establishment of exosome-based drug delivery systems","volume":"329","author":"Wang","year":"2021","journal-title":"J. Contr. Release"},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123548_bib113","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1021\/acsnano.3c04308","article-title":"Facilitating pro-survival mitophagy for alleviating Parkinson's disease via sequence-targeted lycopene nanodots","volume":"17","author":"Xia","year":"2023","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123548_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101316","article-title":"Facet\u2010dependent biodegradable Mn3O4 nanoparticles for ameliorating Parkinson's Disease","volume":"10","author":"Xu","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802896","article-title":"Exosome biochemistry and advanced nanotechnology for next\u2010generation theranostic platforms","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"issue":"45","key":"10.1016\/j.biomaterials.2025.123548_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007949","article-title":"Bioengineering approaches for the advanced organoid research","volume":"33","author":"Yi","year":"2021","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123548_bib117","doi-asserted-by":"crossref","first-page":"2413367","DOI":"10.1002\/advs.202413367","article-title":"Recent advances in nanoenzymes based therapies for glioblastoma: overcoming barriers and enhancing targeted treatment[J]","volume":"12","author":"Wang","year":"2025","journal-title":"Advanced Science"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib118","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/mds.30162","article-title":"Update on treatments for Parkinson's Disease motor Fluctuations\u2013An international parkinson and movement disorder Society evidence\u2010based medicine review","volume":"40","author":"de Bie","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biomaterials.2025.123548_bib119","first-page":"1","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib120","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuron.2018.07.028","article-title":"A cortical pathogenic theory of Parkinson's disease","volume":"99","author":"Foffani","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib121","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","article-title":"Circuit mechanisms of Parkinson's disease","volume":"101","author":"McGregor","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biomaterials.2025.123548_bib122","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2147\/NDT.S213917","article-title":"Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey","author":"Hermanowicz","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100016","article-title":"Mitochondria in brain diseases: bridging structural-mechanistic insights into precision-targeted therapies[J]","volume":"1","author":"Liao","year":"2025","journal-title":"Cell Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib124","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson's disease: how good are they?","volume":"36","author":"Li","year":"2020","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson's disease in the US","volume":"6","author":"Yang","year":"2020","journal-title":"npj Parkinson's Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib128","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/nu10060708","article-title":"Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases","volume":"10","author":"Gerhardt","year":"2018","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123548_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202000632","article-title":"ROS scavenging biopolymers for anti\u2010inflammatory diseases: classification and formulation","volume":"7","author":"Zhang","year":"2020","journal-title":"Adv. Mater. Interfac."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123548_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801899","article-title":"Embryonic stem cells\u2010derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123548_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801313","article-title":"Exosome release is regulated by mTORC1","volume":"6","author":"Zou","year":"2019","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib132","article-title":"Cognition deficits in Parkinson's disease: mechanisms and treatment","author":"Fang","year":"2020","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.biomaterials.2025.123548_bib133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","article-title":"The spectrum of \u201coff\u201d in Parkinson's disease: what have we learned over 40 years?","volume":"51","author":"Chou","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biomaterials.2025.123548_bib134","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123548_bib135","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1002\/anie.201805052","article-title":"Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson's disease","volume":"57","author":"Kwon","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123548_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103222","article-title":"Exosome processing and characterization approaches for research and technology development","volume":"9","author":"Lai","year":"2022","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib137","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.4103\/1673-5374.335143","article-title":"Role of exosomes in the pathogenesis of inflammation in Parkinson's disease","volume":"17","author":"Li","year":"2022","journal-title":"Neural regeneration research"},{"key":"10.1016\/j.biomaterials.2025.123548_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson's Disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123548_bib139","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson's disease","volume":"174","author":"Lunati","year":"2018","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib140","first-page":"1","article-title":"The role and importance of gliah neurotrophical factors in early diagnosis of parkinson disease","volume":"5","author":"Isroilovich","year":"2022","journal-title":"Texas Journal of Medical Science"},{"key":"10.1016\/j.biomaterials.2025.123548_bib141","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"Br. Med. J."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123548_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412548","article-title":"Parkinson's disease modeling using directly converted 3D induced dopaminergic neuron organoids and assembloids","volume":"12","author":"Kim","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121858","article-title":"3D biocomposite culture enhances differentiation of dopamine-like neurons from SH-SY5Y cells: a model for studying Parkinson's disease phenotypes","volume":"290","author":"Fiore","year":"2022","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123548_bib144","doi-asserted-by":"crossref","first-page":"13647","DOI":"10.1021\/acs.analchem.0c03092","article-title":"Facile impedimetric analysis of neuronal exosome markers in Parkinson's disease diagnostics","volume":"92","author":"Fu","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biomaterials.2025.123548_bib145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biomaterials.2018.12.013","article-title":"Gold nanoclusters for Parkinson's disease treatment","volume":"194","author":"Gao","year":"2019","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib146","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1021\/acsnano.1c00453","article-title":"Bioinspired theranostic coordination polymer nanoparticles for intranasal dopamine replacement in Parkinson's disease","volume":"15","author":"Garc\u00eda-Pardo","year":"2021","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123548_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202000515","article-title":"Thermosensitive exosome\u2013liposome hybrid nanoparticle\u2010mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer","volume":"7","author":"Lv","year":"2020","journal-title":"Adv. Sci."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123548_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106723","article-title":"Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123548_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902062","article-title":"Flexible hybrid electronics for digital healthcare","volume":"32","author":"Ma","year":"2020","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123548_bib150","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123548_bib151","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123548_bib152","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123548_bib153","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2018.10.004","article-title":"Recent progress of drug nanoformulations targeting to brain","volume":"291","author":"Khan","year":"2018","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123548_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900513","article-title":"Exosome\u2010guided phenotypic switch of M1 to M2 macrophages for cutaneous wound healing","volume":"6","author":"Kim","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123548_bib156","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/admt.201800488","article-title":"Electronic noses: from advanced materials to sensors aided with data processing","volume":"4","author":"Hu","year":"2019","journal-title":"Advanced Materials Technologies"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib158","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism","volume":"91","author":"Jiang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123548_bib159","doi-asserted-by":"crossref","first-page":"17581","DOI":"10.1021\/acsanm.3c02749","article-title":"Selenium nanoparticles as potential drug-delivery systems for the treatment of Parkinson's disease","volume":"6","author":"Kalcec","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"issue":"6414","key":"10.1016\/j.biomaterials.2025.123548_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8407","article-title":"Poly (ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson's disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123548_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101764","article-title":"Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: a systematic review and meta-analysis","volume":"82","author":"Nila","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biomaterials.2025.123548_bib162","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: from 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123548_bib163","article-title":"Parkinson's disease: current drug therapy and unraveling the prospects of nanoparticles","volume":"58","author":"Paul","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123548_bib164","first-page":"5510","article-title":"Bioactive ceria nanoenzymes target mitochondria in reperfusion injury to treat ischemic stroke","volume":"18","author":"Liao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123548_bib165","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","author":"Liao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123548_bib166","article-title":"Advanced nano delivery system for stem cell therapy for Alzheimer's disease","author":"Pan","year":"2024","journal-title":"Biomaterials"},{"issue":"27","key":"10.1016\/j.biomaterials.2025.123548_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201406","article-title":"Engineered exosomes with independent module\/cascading function for therapy of Parkinson's disease by multistep targeting and multistage intervention method","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"50","key":"10.1016\/j.biomaterials.2025.123548_bib168","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson's disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib169","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-024-00866-0","article-title":"Key shifts in frontoparietal network activity in Parkinson's disease","volume":"11","author":"Sosnik","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115178","article-title":"G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis","volume":"44","author":"Stykel","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2025.123548_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102438","article-title":"Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson's disease","volume":"58","author":"Xu","year":"2024","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib172","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00401-025-02853-y","article-title":"A quantitative lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease","volume":"149","author":"Bernhardt","year":"2025","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biomaterials.2025.123548_bib173","series-title":"Beyond Dopamine: Novel Therapeutic Pathways for Parkinson's disease Through Receptor Signaling","author":"Bhushan","year":"2025"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib174","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s43587-024-00760-7","article-title":"Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk","volume":"5","author":"Chew","year":"2025","journal-title":"Nature Aging"},{"key":"10.1016\/j.biomaterials.2025.123548_bib175","first-page":"1","article-title":"Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson's disease","author":"Yuan","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib176","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41531-025-00870-y","article-title":"A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease","volume":"11","author":"Dou","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib177","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s12035-024-04400-4","article-title":"Insomnia in Parkinson's disease: causes, consequences, and therapeutic approaches","volume":"62","author":"Duan","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123548_bib178","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180478","article-title":"PINK1 is a target of T cell responses in Parkinson's disease","volume":"135","author":"Williams","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"6736","key":"10.1016\/j.biomaterials.2025.123548_bib179","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.adp3645","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson's disease","volume":"387","author":"Wu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123548_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102651","article-title":"Drug repositioning for Parkinson's disease: an emphasis on artificial intelligence approaches","author":"Karimi-Sani","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biomaterials.2025.123548_bib181","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbi.2024.10.039","article-title":"Deep brain stimulation halts Parkinson's disease-related immune dysregulation in the brain and peripheral blood","volume":"123","author":"McFleder","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"121","key":"10.1016\/j.biomaterials.2025.123548_bib182","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated \u03b1-synuclein in Parkinson's disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123548_bib183","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/brain\/awad072","article-title":"Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study","volume":"146","author":"Joza","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123548_bib184","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jama.2021.10207","article-title":"Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial","volume":"326","author":"Bluett","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","article-title":"Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related Parkinson's disease","volume":"149","author":"Sekiya","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123548_bib186","article-title":"Explainable artificial intelligence to diagnose early Parkinson's disease via voice analysis","volume":"15","author":"Shen","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123548_bib187","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acsnano.9b06453","article-title":"A self-assembled \u03b1-synuclein nanoscavenger for Parkinson's disease","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123548_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705388","article-title":"Looking into the future: toward advanced 3D biomaterials for stem\u2010cell\u2010based regenerative medicine","volume":"30","author":"Liu","year":"2018","journal-title":"Adv. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225004673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225004673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:06:00Z","timestamp":1779717960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225004673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":188,"alternative-id":["S0142961225004673"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123548","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in exosome-based nanodelivery systems for Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123548"}}